Health Catalyst, Inc.
HCATNASDAQHealthcare● Active
$1.81
$-0.12(-5.97%)
Market Cap$134095442
P/E Ratio—
52W High$4.291
52W Low$0.955
Health Catalyst, Inc. (HCAT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HCAT · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.31B | $0.31B | $0.30B | $0.28B | $0.24B |
| Cost of Revenue | $0.21B | $0.17B | $0.16B | $0.14B | $0.12B |
| Gross Profit | $0.10B | $0.14B | $0.13B | $0.13B | $0.12B |
| Gross Margin %(computed) | 33.47% | 45.92% | 44.55% | 48.21% | 48.60% |
| Operating Expenses | |||||
| R&D Expenses | $0.05B | $0.06B | $0.07B | $0.08B | $0.06B |
| G&A Expenses | $0.05B | $0.06B | $0.08B | $0.06B | $0.09B |
| Total Operating Expenses | $0.14B | $0.21B | $0.26B | $0.27B | $0.26B |
| Operating Income | ($0.04B) | ($0.07B) | ($0.13B) | ($0.14B) | ($0.14B) |
| Operating Margin %(computed) | -11.60% | -22.77% | -42.88% | -50.68% | -59.38% |
| Interest Income | $0.01B | $0.02B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.01B | $0.01B | $0.02B |
| Income Before Tax | ($0.18B) | ($0.07B) | ($0.12B) | ($0.14B) | ($0.16B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.01B) |
| Net Income | ($0.18B) | ($0.07B) | ($0.12B) | ($0.14B) | ($0.15B) |
| Net Margin %(computed) | -57.20% | -22.67% | -39.92% | -49.74% | -63.33% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.55 | $-1.15 | $-2.09 | $-2.56 | $-3.23 |
| Wtd Avg Shares | 0.07B | 0.06B | 0.06B | 0.05B | 0.05B |
| EBITDA | $0.01B | ($0.01B) | ($0.07B) | ($0.08B) | ($0.10B) |
| EBITDA Margin %(computed) | 4.63% | -3.47% | -23.07% | -30.02% | -42.03% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Health Catalyst, Inc. data
About Health Catalyst, Inc. (HCAT) Income Statement
Health Catalyst, Inc. (HCAT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HCAT reported revenue of $0.31B, gross profit of $0.10B (gross margin 33.47%), and net income of ($0.18B) — a net profit margin of -57.20%.
Frequently asked questions
HCAT · 4 questionsHealth Catalyst, Inc. (HCAT) reported revenue of $0.31B for 2025, up 1.5% year-over-year.
HCAT revenueHCAT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08